However, new research has found that up to one in 10 people may have genetic variants that make them resistant to the effects of these drugs
A five-month treatment with PEGylated exenatide (NLY01) was found to decrease the secretion of complement 1q (C1q), IL-1, and TNF- by primary mouse microglia, thereby limiting the conversion of astrocytes to a neurotoxic phenotype
John Whyte, chief medical officer at WebMD and a board-certified internist with expertise in drug development and medical policy, told Flow Space
Not Anyone looking for clinically proven GLP-1 treatment should look elsewhere
There isnt any research to suggest that a GLP-1 patch will work in the future, says Adam Gilden, MD, an associate professor and the associate director of the weight management clinic at the University of Colorado School of Medicine in Aurora
Regular follow-ups help ensure the treatment is working effectively and safely for you